产后女性急性髂股深静脉血栓腔内治疗的中期结局
本研究回顾性分析11例产后急性髂股深静脉血栓接受溶栓和支架治疗的患者,并与68例非产后女性比较。
要点
- 产后女性髂股DVT溶栓支架后1年累积通畅率64%,低于非产后女性的93%。
- 再干预在完全闭塞病例中均未成功,强调初始彻底溶栓和充分支架置入的重要性。
核心结论
- 经皮介入实现早期血栓清除和静脉支架置入可降低产后女性髂股DVT的PTS严重程度,是保守治疗的有利替代。
- 彻底溶栓和充分支架置入对预防再闭塞至关重要,再干预成功率较低。
研究设计与样本
- 回顾性分析2012年1月至2017年12月单中心收治的产后急性髂股DVT接受溶栓和支架治疗的患者11例。
- 与同期收治的非产后女性68例进行比较。
主要发现
- 产后组中位年龄28岁(范围22-41岁),干预在产后中位3周(范围2-12周)进行。
- 无干预相关主要或次要并发症报告。
- 产后组6个月中位Villalta评分3,12个月改善至2;2例(18%)为轻度PTS,无中重度PTS。
关键数值与推荐
- 产后组55%(6/11)需要再干预,非产后组29%(20/68)。
- 首次再干预平均时间62天(范围7-233天)。
- 100%血管闭塞病例再干预均未成功(4/11),部分闭塞病例再干预成功(2/11)。
- 所有再干预病例均与初始手术未能完全溶解血栓和支架覆盖残余病变的技术失败相关。
临床怎么用
- 对于产后急性髂股DVT,可考虑经皮介入溶栓和支架置入以降低PTS严重程度。
- 初始手术应追求彻底溶栓和充分支架覆盖病变,以减少再闭塞和再干预风险。
局限性
- 回顾性单中心小样本研究,产后组仅11例。
- 需要进一步研究以明确产后髂股DVT的适当管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The development of post-thrombotic syndrome (PTS) after iliofemoral deep vein thrombosis (DVT) continues to be a considerable issue for both pregnant and postpartum women with rates as high as 70% among those managed with anticoagulation alone. This study aims to characterize the outcomes of interventional treatment for acute iliofemoral DVT in this at-risk population. METHODS: A retrospective analysis of all postpartum patients treated for acute iliofemoral DVT with lysis and stenting between January 2012 and December 2017 at a referral center. Patient demographics, risk factors, procedural factors. and complications were collected. Post-treatment outcomes were compared with all nonpostpartum females treated within the same time period. These included the severity of PTS evaluated using the Villalta scale, duration of vessel patency and factors affecting reintervention timing and success. Further detailed review of cases needing reintervention was also conducted through a retrospective review of documentation and an analysis of all imaging by a consultant radiologist. RESULTS: A total of 11 postpartum women were identified. The median age was 28 years (range, 22-41 years) and intervention was performed at a median of 3 weeks after birth (range 2-12 weeks). No major or minor complications associated with intervention were reported in any patients. The median Villalta score was 3 at 6 months, improving to 2 at 12 months. Overall, two patients were classified as mild having PTS (18%), with no cases of moderate to severe PTS. On comparison with nonpostpartum (n = 68) Villalta scores, no significant difference in outcome was observed at 6 months (median score, 3; range, 0-15 months; P = .95) or at 1 year (median score, 1; range, 0-15; P = .84). Cumulative patency at 1 year was found to be 64% in postpartum women compared with 93% in nonpostpartum women. The postpartum state was found to be a significant predictor of cumulative patency loss (hazard ratio, 0.10; 95% confidence interval, 0.02-0.62; P = .01). However, no significant difference in primary and primary-assisted patency was observed. Of the postpartum patients, 55% required reintervention (6/11) compared with 29% of nonpostpartum patients (20/68). The mean time to initial reintervention was 62 days (range, 7-233 days). Reintervention was unsuccessful in all cases presenting with 100% vessel occlusion (4/11), but successful in both cases with partial occlusion (2/11). Analysis of the etiologic factors associated with reintervention revealed that all reintervention cases were associated with technical failure to fully lyse and stent beyond residual disease at the initial procedure. No technical, flow, or hematologic factors were identified in the four cases that retained primary patency. CONCLUSIONS: This study suggests that percutaneous intervention to achieve early thrombus removal and venous stenting provides a favorable alternative to conservative therapies owing to its potential to decrease the severity of PTS. Completion of lysis and adequate stenting of disease is essential to prevent reocclusion, for which reintervention carries a lower likelihood of success. Further research is warranted to further characterize the appropriate management of postpartum women with iliofemoral DVT.
引用
- Lestak K, Pouncey AL, Gwozdz A, et al. Midterm outcomes in postpartum women following endovenous treatment for acute iliofemoral deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31879231. doi:10.1016/j.jvsv.2019.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。